1. Home
  2. CXAI vs MRNS Comparison

CXAI vs MRNS Comparison

Compare CXAI & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CXAI
  • MRNS
  • Stock Information
  • Founded
  • CXAI N/A
  • MRNS 2003
  • Country
  • CXAI United States
  • MRNS United States
  • Employees
  • CXAI N/A
  • MRNS N/A
  • Industry
  • CXAI EDP Services
  • MRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CXAI Technology
  • MRNS Health Care
  • Exchange
  • CXAI Nasdaq
  • MRNS Nasdaq
  • Market Cap
  • CXAI 33.9M
  • MRNS 29.9M
  • IPO Year
  • CXAI N/A
  • MRNS 2014
  • Fundamental
  • Price
  • CXAI $1.56
  • MRNS $0.55
  • Analyst Decision
  • CXAI
  • MRNS Buy
  • Analyst Count
  • CXAI 0
  • MRNS 12
  • Target Price
  • CXAI N/A
  • MRNS $4.28
  • AVG Volume (30 Days)
  • CXAI 987.4K
  • MRNS 1.5M
  • Earning Date
  • CXAI 11-12-2024
  • MRNS 03-04-2025
  • Dividend Yield
  • CXAI N/A
  • MRNS N/A
  • EPS Growth
  • CXAI N/A
  • MRNS N/A
  • EPS
  • CXAI N/A
  • MRNS N/A
  • Revenue
  • CXAI $7,200,000.00
  • MRNS $31,466,000.00
  • Revenue This Year
  • CXAI $3.86
  • MRNS $14.97
  • Revenue Next Year
  • CXAI $100.00
  • MRNS $57.65
  • P/E Ratio
  • CXAI N/A
  • MRNS N/A
  • Revenue Growth
  • CXAI N/A
  • MRNS 1.63
  • 52 Week Low
  • CXAI $1.09
  • MRNS $0.22
  • 52 Week High
  • CXAI $7.07
  • MRNS $10.50
  • Technical
  • Relative Strength Index (RSI)
  • CXAI 43.46
  • MRNS 70.09
  • Support Level
  • CXAI $1.42
  • MRNS $0.54
  • Resistance Level
  • CXAI $1.58
  • MRNS $0.55
  • Average True Range (ATR)
  • CXAI 0.13
  • MRNS 0.01
  • MACD
  • CXAI -0.02
  • MRNS -0.01
  • Stochastic Oscillator
  • CXAI 22.95
  • MRNS 93.00

About CXAI CXApp Inc.

CXApp Inc is a workplace experience platform for enterprise customers. It is a SaaS product for enterprise organizations, distributing a mobile app to all employees within the organization. It includes a content management system (or CMS) so customers can adjust configurations for their workplace settings autonomously and spontaneously. Its technologies and solutions help enterprise customers deliver a comprehensive business journey in a work 'from anywhere' world for employees, partners, customers, and visitors. CXApp offers native mapping, analytics, on-device positioning (or ODP), and application technologies that bring people together.

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Share on Social Networks: